Published 2 days ago • loading... • Updated 2 days ago

Skyhawk Therapeutics Announces its Founding Scientific Advisory Board Chairman Receives the American Cancer Society's 2026 Medal of Honor

On Monday, the American Cancer Society awarded its 2026 Medal of Honor to Dr. Tyler Jacks, founding chairman of Skyhawk Therapeutics' Scientific Advisory Board, recognizing his commitment to cancer research.
Jacks, a biology professor at the Massachusetts Institute of Technology , pioneered genetically engineered mouse models to study tumor evolution and has authored more than 300 scientific papers exploring cancer resistance mechanisms.
Jacks earned his doctorate at the University of California, San Francisco, studying under 1989 Nobel Prize winner Dr. Harold Varmus and has received the Paul Marks Prize and AACR Outstanding Achievement Award.
Skyhawk's Co-founder and CEO Bill Haney called the recognition "dazzling," noting the company's RNA revolution work has been transformed by Jacks' insight and praising his "generosity of spirit."
Dr. Benjamin L. Ebert, President and CEO of Dana-Farber Cancer Institute, stated Jacks is "a truly extraordinary scientist and leader across many fields," crediting him with guiding scientific programs addressing unmet disease needs.

Insights by Ground AI

25 Articles

Bennington Banner

+24 Reposted by 24 other sources

Center

Skyhawk Therapeutics Announces its Founding Scientific Advisory Board Chairman Receives the American Cancer Society's 2026 Medal of Honor

Dr. Tyler Jacks, founding chairman of Skyhawk's Scientific Advisory Board, receives the American Cancer Society's highest award, the Medal of Honor, first awarded in 1949, for his tireless commitment to addressing the complexities of cancer.

2 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year